Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks to grow its pipeline.| STAT
Television advertising for pharmaceutical brands has evolved beyond general demographic targeting to enable condition-specific audience layering that eliminates wasted impressions while maintaining the mass reach needed for awareness campaigns. “Where we used to do a broad kind of demo targeting, now we can bring in these condition-based audiences that allow us to become more precise,” [...]| Beet.TV
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.| STAT
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a pharma CEO and a toddler in a tuxedo.| STAT
Can "food noise" be measured? Telehealth giant Ro is rolling out a new scale for obesity care.| STAT
TrumpRx and a most-favored nation policy won’t lower prices for patients, writes the CEO and co-founder of I-MAK.| STAT
There’s a gray market in GLP-1s. It’s dangerous, but for people like this author, the risks feel worth it.| STAT
Advocacy groups form a buyer's club to obtain generic versions of pricey Vertex cystic fibrosis drug.| STAT
The FDA delivers a split decision on GSK’s blood cancer drug Blenrep, approving its use in some cases.| STAT
Fertility benefits firms hope Trump's IVF announcement will help them win over more clients.| STAT
New analysis finds the median net price for 154 newly launched drugs, when adjusted for inflation and manufacturer discounts, rose by 51% between 2022 and 2024.| STAT
This was an extremely difficult post to write. I live in war-ravaged Portland, Oregon, and it is like World War II here. Think Berlin at the end. Nothing but chaos, death and destruction. A burning h| Science-Based Medicine
Enhertu can help patients with breast cancer when given earlier in the disease, according to data presented at the ESMO Conference 2025.| STAT
Overview New York, NY – Oct 20, 2025 – Global Vaccine Contract Manufacturing Market size is expected to be worth around US$ 5.0 Billion by 2033 from US$ 2.4 Billion in 2024, growing at a CAGR of 7.6% during the forecast period 2025 to 2033. A leading biopharmaceutical solutions provider has announced the establishment of comprehensive Vaccine Contract Manufacturing services […] The post Vaccine Contract Manufacturing Market Registers Robust CAGR of 7.6% from 2025–2033 appeared fi...| Market.us Media
Overview New York, NY – Oct 20, 2025 – Global Fetal Bovine Serum Market size is expected to be worth around US$ 6.4 Billion by 2033 from US$ 1.9 Billion in 2024, growing at a CAGR of 14.2% during the forecast period 2025 to 2033. The global Fetal Bovine Serum (FBS) market is witnessing significant expansion, […] The post Fetal Bovine Serum Market on a Steady Growth Path, CAGR 14.2% Forecasted Through 2033 appeared first on Market.us Media.| Market.us Media
Overview New York, NY – Oct 20, 2025 – Global Drug Discovery Market size is expected to be worth around USD 77.7 Billion by 2024 from USD 173.5 Billion in 2033, growing at a CAGR of 9.5% during the forecast period 2025 to 2033. The field of drug discovery continues to play a pivotal role in addressing global health challenges […] The post Drug Discovery Market Toward USD 173.5 Billion Milestone appeared first on Market.us Media.| Market.us Media
Overview New York, NY – Oct 20, 2025 – Global Nephrology Drugs Market size is expected to be worth around USD 27.8 Billion by 2033 from USD 16.7 Billion in 2024, growing at a CAGR of 5.8% during the forecast period from 2025 to 2033. The Nephrology Drugs Market plays a vital role in managing and treating kidney-related disorders such […] The post Nephrology Drugs Market Set for Steady Expansion, Projected to Hit USD 27.8 Billion by 2033 appeared first on Market.us Media.| Market.us Media
Overview New York, NY – Oct 20, 2025 – Global Empty Capsules Market size is expected to be worth around USD 6.4 Billion by 2033 from USD 3.5 Billion in 2024, growing at a CAGR of 6.8% during the forecast period from 2025 to 2033. The Empty Capsules Market represents a crucial segment of the pharmaceutical and nutraceutical industries, facilitating […] The post Empty Capsules Market Set for Strong Growth, Expected to Hit USD 6.4 Billion by 2033 appeared first on Market.us Media.| Market.us Media
Overview The aquaculture industry is expanding rapidly, with global output reaching a record 223.2 million tonnes in 2022. Of this, aquaculture contributed 130.9 million tonnes—more than half of all aquatic animals for food. Rising farming volumes have increased exposure to pathogens, making vaccination a vital biosecurity measure. Autogenous vaccines, developed from farm-specific isolates, are gaining […] The post Autogenous Vaccine for Aquaculture Market Eyes USD 900 Million Milestone 2...| Market.us Media
Overview New York, NY – Oct 20, 2025 – Global Chemoinformatics Market was sized at US$ 4.3 Billion in 2024 and is expected to reach US$ 15.59 Billion growing at the compound annual growth rate (CAGR) of 15.7% from 2025 to 2033. Chemoinformatics, also known as cheminformatics, is an interdisciplinary field that integrates chemistry, computer science, […] The post Chemoinformatics Market Valued at USD 4.3 Billion in 2024, Set for Robust Expansion Through 2033 appeared first on Market.us ...| Market.us Media
Global Geriatric Medicines Market size is expected to be worth around US$ 328.9 Billion by 2033 from US$ 170.1 Billion in 2024.| Market.us Media
The country’s biotech firms are one to two years away from US commercialisation, while drug makers are focused on the huge domestic market.| Australian Financial Review
A new oral drug stands to become the first prescription pill specifically designed to regrow hair in both women and men. If approved following current Phase 3 trials, it would be the first new treatment for pattern hair loss in nearly 30 years – and the first oral therapy for women approved by the…| New Atlas
President Donald Trump has, across two administrations, sought to lower drug prices for Americans, most recently with executive order “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” Margherita Colangelo explains why his order is unlikely to accomplish its goal. Read it at ProMarket >>| ProMarket
Many people take supplements alongside prescription drugs without realizing the risks. The post The Growing Problem of Supplement–Drug Interactions in Seniors first appeared on Science-Based Medicine.| Science-Based Medicine
Previous research has shown incomplete and highly variable removal efficiencies of PPCPs between chemicals and WWTPs. The post Studying pharmaceutical and personal care product levels in municipal wastewater and biosolids appeared first on Environmental Science & Engineering Magazine.| Environmental Science & Engineering Magazine
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]| Citizens Against Government Waste
By: Chris Beckham On April 16, the Trump Administration (Administration) initiated a national security investigation into pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 (Section 232).[1] The investigation was initiated one day after President Trump’s executive order to lower drug prices, which called for “promot[ing] a more . . . resilient pharmaceutical value […] The post Section 232 Blues: The Trump Administration’s National Security ...| Wake Forest Law Review
Sarepta Therapeutics' dealings with FDA are being monitored by law firms, financial institutions, news media, and the Trump Administration.| Poliscio Analytics LLC
Global Natural Astaxanthin Market Was Valued at USD 134.5 Million in 2024 and Is Expected To Reach USD 248.3 Million by 2032.| Market.us Media
Global Ayurveda Market is projected to reach USD 200.2 Billion by 2034. In 2024, the market size was USD 18.2 Billion.| Market.us Media
Global Mice Model Market is projected to reach USD 3.27 Billion by 2034, up from USD 1.68 Billion in 2024.| Market.us Media
Global Direct Oral Anticoagulants (DOACs) Market is projected to reach approximately US$ 96.5 billion by 2034.| Market.us Media
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.| STAT
Investors are in panic as Australian drug companies could be the next victims in an expansion of the US trade war.| Australian Financial Review
Prime Minister Anthony Albanese and Opposition Leader Peter Dutton say the Pharmaceutical Benefits Scheme, a cornerstone of Australia's health system, will never be a negotiating chip in US President Donald Trump's ongoing tariff campaign.| www.abc.net.au
CANNES – The fragmentation that has long plagued television advertising may finally be giving way to consolidation, creating new opportunities for precision targeting in healthc...| Beet.TV - The Root to the Media Revolution
Discover the groundbreaking advancements in Multi-Cancer Early Detection (MCED) technologies that enables healthcare providers to detect cancers earlier.| blog.marketresearch.com
Violet Butler, MJLST Note/Comment Editor Sex and drugs don’t mix. Or do they? A scroll on the popular LGBTQ+ hookup and dating app Grindr will...| LawSci Forum
Precision medicine is reshaping healthcare by tailoring treatments to a person’s genetic makeup, lifestyle, and environment.| Market Research Blog
There are 1.5 million children with autism in America, and the United States is the largest market for autism treatment programs. This is a long-term growth market.| Market Research Blog
Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.| ProMarket
Consumer preferences for convenient and palatable alternatives to traditional pill-based supplements are the primary drivers of the global chewable supplements market, which is currently experiencing substantial growth.| Market Research Blog
The global prefilled syringes market is projected to grow from USD 3,024 million in 2024 to USD 4,972 million by 2035, according to Roots Analysis.| blog.marketresearch.com
The impact of GLP-1 drugs seems to be real, not a fad. But they’re an expensive way to deal with problems that have been created by Big Food.| the next wave
There are a number of innovative applications that dry ice is being used for in the medical industry—it doesn't stop at basic refrigeration!| Dry Ice Corp
Statin drugs cause muscle weakness and pain by suppressing cannabinoid receptor genes. The post Statins Dysregulate the Endocannabinoid System appeared first on Project CBD.| Project CBD
In the late 1800s, quack medicine was rising concern in the United States. Harmful ingredients and ineffective medicines were a danger to the health of the country. This exhibit identifies the milestones in the federal government's efforts to regulate the drug market. … Continue reading The Great American Fraud: Quacks and quackery in medicine→| Melnick Medical Museum
The burgeoning weight-loss drug industry could be worth as much as $200 billion within the next decade, according to Barclays bank.| CNBC
Psychedelic trips often unfold without issues, but what if a trip needs to be stopped? Drugs such as benzodiazepines and antipsychotics are recommended as rescue medications and have been around for…| Psychedelic Science Review
